Critical Care
Merck Withdraws Acute Pain Medication
As the result of a new study showing an increased risk of heart attack and stroke after 18 months of treatment with an arthritis and acute pain medication called rofecoxib, Merck & Co. has announced a voluntary worldwide withdrawal of the drug from the market. More...18 Oct 2004
New
Gold Member
Handheld Blood Glucose Analyzer
STAT-Site
New
Gold Member
Neonatal Heel Incision Device
Tenderfoot
New
Medical-Grade Display
HL2316SHTB
New
Resorbable Bovine Collagen Membrane
GenDerm
In Other News
Nitrite Therapy for Babies with Pulmonary Hypertension
Kidney Disease Increases Heart Risks
VEGF Aids Development of Asthma
Siblings of Infants with Heart Defects Are at Risk
New Pain Drug Boosts Effects of Opioids
Role of Astrocytes Suggests Target for Stroke Therapy
End-of-Life Choices Affected by Doctors' Outlook
Under-Recognized Subclavian Artery Stenosis
Oxycodone That Can't Be Abused or Misused
Drug Reduces Stroke Risk During Bypass Surgery
HLA Genes Have Role in Preterm Delivery
Pig Tissue Transplant May Reduce Stroke Damage
Nine Factors Found to Predict Heart Attacks
New Class of Compounds May Revive Failing Hearts
Zoll Licenses Software for AEDs from Research Center
Device Removes Brain Clots in Stroke Patients
Brain Can Generate Pain without Stimulus
Public AEDs Double Survival of Cardiac Arrest Patients
Blood Thinner Prevents DVT in Hospital Patients
Annuloplasty Band for Heart Valve Repair
Worsening Lung Function in Young Asthmatics
New Cardiac Device to Detect Coronary Artery Disease
45% of Specialists Report Recent Medical Error
HospiMedica Critical Care channel provides timely reporting on emergency medicine, intensive care, anesthesia, neonatal care, patient monitoring, respiratory care, infection control, and more hospital related subjects.